Guardion Health Sciences, Inc. Gains 59.29%
Guardion Health Sciences, Inc. (GHSI:NASDAQ) jumped higher at $18, a gain of 59.3%. On Fri, Aug 23, 2024, GHSI:NASDAQ touched a New 2-Week High of $18. The stock got featured on our News Catalysts scanner on Wed, Aug 21, 2024 at 07:33 PM in the 'INVESTOR UPDATE' category. From Fri, Aug 09, 2024, the stock recorded 50.00% Up Days and 54.55% Green Days
About Guardion Health Sciences, Inc. (GHSI:NASDAQ)
Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.
Top 10 Gainers:
- Scopus BioPharma Inc. (SCPS:NASDAQ), 200%
- Portage Biotech Inc. (PRTG:NASDAQ), 121.4%
- Sequans Communications S.A. (SQNS:NYSE), 111.71%
- Momentus Inc. (MNTS:NASDAQ), 84.05%
- Guardion Health Sciences, Inc. (GHSI:NASDAQ), 59.29%
- ReTo Eco-Solutions, Inc. (RETO:NASDAQ), 53.85%
- Applied DNA Sciences, Inc. (APDN:NASDAQ), 38.8%
- Elevai Labs Inc. (ELAB:NASDAQ), 33.48%
- QT Imaging Holdings Inc Com (QTI:NASDAQ), 32.57%
- Perma-Pipe International Holdings, Inc. (PPIH:NASDAQ), 27.78%